BioSpace News Archive

Year-end Report 2020 and an operational update will be presented by CEO Marty J Duvall and members of Oncopeptides Leadership team, Thursday February 18, 2021 at 14:00 (CET).

Swedish Orphan Biovitrum AB announces its results for the fourth quarter and full-year 2020.

Amarin Corporation plc announced that John F. Thero, Amarin’s president and chief executive officer, is scheduled to present general company updates at the following investor conferences scheduled in February and March

Atopic dermatitis is a chronic, pruritic, inflammatory dermatosis that is believed to affect an estimated number of 26M patients in North America, EU, and Japan

BioCryst Pharmaceuticals, Inc. announced that the company will present at the Cowen 41st Annual Healthcare Conference on Thursday, March 4, 2021 at 12:10 p.m. ET and the Barclays Annual Healthcare Conference on Thursday, March 11, 2021 at 8:00 a.m. ET.

Mereo BioPharma Group plc, a clinical-stage biopharmaceutical company focused on oncology and rare diseases, announced that Dr. Denise Scots-Knight, Chief Executive Officer of Mereo, will participate in a fireside chat at the 10th Annual SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 8:00am Eastern Time.

OpSens Inc., a medical device cardiology-focused company commercializing a second-generation fiber optic pressure guidewire to diagnose and treat coronary disease, has announced it has received CE marking for the OptoWire III, the latest generation of its flagship product.

Continued CMS progress made with issuance of HCPCS Level II Code for ReWalk Exoskeleton enabling an upcoming application for coverage

Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2020 results

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its financial results for the year ended December 31, 2020, on Thursday, February 25, 2021, before the U.S. financial markets open